Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation

Published:2017-03-03 Issue:7 Volume:143 Page:1281-1292
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Döring Michaela,Cabanillas Stanchi Karin Melanie,Queudeville Manon,Feucht Judith,Blaeschke Franziska,Schlegel Patrick,Feuchtinger Tobias,Lang Peter,Müller Ingo,Handgretinger Rupert,Heinz Werner J.

Funder

Stefan-Morsch-Stiftung, Birkenfeld, Germany

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-017-2369-7/fulltext.html

Reference53 articles.

1. Abbasi S, Shenep JL, Hughes WT, Flynn PM (1999) Aspergillosis in children with cancer: a 34-year experience. Clin Infect Dis 29:1210–1219. doi: 10.1086/313445

2. Barchiesi F, Schimizzi AM, Caselli F, Giannini D, Camiletti V, Fileni B, Giacometti A, Di Francesco LF, Scalise G (2001) Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans. J Antimicrob Chemother 48:769–773

3. Bennett F, Saksena AK, Lovey RG et al. (2006) Hydroxylated analogues of the orally active broad spectrum antifungal, Sch 51048 (1), and the discovery of posaconazole [Sch 56592; 2 or (S, S)-5] Bioorg Med Chem Lett 16:186–190 doi: 10.1016/j.bmcl.2005.09.031